Institut Pasteur de Tunis

Tunisie

 
Quantité totale PI 15
Rang # Quantité totale PI 100 624
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 339 187

Brevets

Marques

2 0
1 0
12 0
0
 
Dernier brevet 2022 - Anti-tenascin-c (tnc) single-dom...
Premier brevet 1995 - Vaccine composition comprising r...

Derniers inventions, produits et services

2022 Invention Anti-tenascin-c (tnc) single-domain antibodies (nanobodies) and use thereof. aaa is G or A iii) A...
2019 Invention Multi-epitopic peptide compounds and vaccines against leishmaniasis. Leishmania as well as to pha...
Invention Multi-epitopic peptide compounds and vaccines against leishmaniasis. LeishmaniaLeishmania as well...
Invention Anti-cancer and disintegrin scorpion venoms. Buthus occitanus tunetanusButhus occitanus tunetanus...
2017 Invention Lebecetin, a c-type lectin, as neovascularization inhibitor. The present invention relates to leb...
2013 Invention Combination vaccine for the treatment of leishmaniasis. The invention relates to a combination of...
2009 Invention Variable domains of camelid heavy-chain antibodies directed against androctonus autralis hector t...
Invention Use of a dead-box rna helicase for inducing cytokine production. The invention relates to the use...
2008 Invention Composition comprising the n-terminal region of histone h2b of leishmania—use thereof for inducin...
Invention Method for the production of high-level soluble human recombinant interferon alpha in e. coli and...
Invention Genes associated with leishmania parasite virulence. Leishmania.
2007 Invention Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis o...
Invention Recombinant pichia pastoris strains and process for the production of recombinant human interfero...
2006 Invention Leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic app...
Invention Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical an...
Invention Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing ...
Invention Leishmania antigens suitable for a diagnostic kit of leishmania. A purified Leishmania infantum p...
2004 Invention Use of zkw peptide for preparing an inhibitor drug against platelet aggregation. The invention re...
2003 Invention Gene associated with leishmania parasite virulence. Leishmania.
2002 Invention Gene associated with leishmania parasite virulence. The invention relates to the field of combati...
1995 Invention Vaccine composition comprising recombinant bcg expressing gp63 fusion protein. The invention conc...